{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:15:16Z","timestamp":1786990516405,"version":"build-2736575974"},"reference-count":45,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2008,3,1]],"date-time":"2008-03-01T00:00:00Z","timestamp":1204329600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2008,3]]},"DOI":"10.1016\/j.ijcard.2007.04.062","type":"journal-article","created":{"date-parts":[[2007,6,23]],"date-time":"2007-06-23T07:08:37Z","timestamp":1182582517000},"page":"85-93","source":"Crossref","is-referenced-by-count":43,"title":["Comparison of angiotensin converting enzyme inhibition and angiotensin II receptor blockade for the prevention of experimental autoimmune myocarditis"],"prefix":"10.1016","volume":"125","author":[{"given":"Thomas J.","family":"Bahk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melvin D.","family":"Daniels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan S.","family":"Leon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kegiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M.","family":"Engman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijcard.2007.04.062_bib1","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S0002-9343(97)00331-8","article-title":"Inflammatory myocardial diseases and cardiomyopathies","volume":"102","author":"Pisani","year":"1997","journal-title":"Am J Med"},{"key":"10.1016\/j.ijcard.2007.04.062_bib2","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1006\/clin.1997.4412","article-title":"Epidemiology and estimated population burden of selected autoimmune diseases in the United States","volume":"84","author":"Jacobson","year":"1997","journal-title":"Clin Immunol Immunopathol"},{"key":"10.1016\/j.ijcard.2007.04.062_bib3","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1056\/NEJM200011093431908","article-title":"Myocarditis","volume":"343","author":"Feldman","year":"2000","journal-title":"N Engl J Med"},{"issue":"Suppl O","key":"10.1016\/j.ijcard.2007.04.062_bib4","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1093\/eurheartj\/16.suppl_O.168","article-title":"Treatment of chronic myocarditis with corticosteroids","volume":"16","author":"Kuhl","year":"1995","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ijcard.2007.04.062_bib5","doi-asserted-by":"crossref","first-page":"515","DOI":"10.2165\/00003495-199652040-00005","article-title":"Recognition and optimum management of myocarditis","volume":"52","author":"Caforio","year":"1996","journal-title":"Drugs"},{"key":"10.1016\/j.ijcard.2007.04.062_bib6","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/S0891-5520(20)30539-0","article-title":"Chagas disease. American trypanosomiasis","volume":"7","author":"Kirchhoff","year":"1993","journal-title":"Infect Dis Clin North Am"},{"key":"10.1016\/j.ijcard.2007.04.062_bib7","series-title":"Myocarditis in The Heart","first-page":"1256","author":"Wenger","year":"1990"},{"key":"10.1016\/j.ijcard.2007.04.062_bib8","series-title":"Cardiomyopathies, Chapter XIV in Scientific American Medicine","first-page":"1","author":"Dec","year":"1998"},{"key":"10.1016\/j.ijcard.2007.04.062_bib9","doi-asserted-by":"crossref","first-page":"841","DOI":"10.3109\/03602538409041080","article-title":"Captopril: pharmacology, metabolism and disposition","volume":"15","author":"Migdalof","year":"1984","journal-title":"Drug Metab Rev"},{"key":"10.1016\/j.ijcard.2007.04.062_bib10","doi-asserted-by":"crossref","first-page":"723","DOI":"10.2174\/1381612033455440","article-title":"Angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists in experimental myocarditis","volume":"9","author":"Godsel","year":"2003","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.ijcard.2007.04.062_bib11","doi-asserted-by":"crossref","first-page":"226","DOI":"10.2165\/00002512-199507030-00007","article-title":"Captopril. A review of its pharmacology and therapeutic efficacy after myocardial infarction and in ischaemic heart disease","volume":"7","author":"Plosker","year":"1995","journal-title":"Drugs Aging"},{"issue":"Suppl 1","key":"10.1016\/j.ijcard.2007.04.062_bib12","first-page":"27","article-title":"Captopril in the treatment of congestive heart failure","volume":"12","author":"Di Bianco","year":"1987","journal-title":"Herz"},{"key":"10.1016\/j.ijcard.2007.04.062_bib13","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.1172\/JCI116513","article-title":"Enhanced expression of superoxide dismutase messenger RNA in viral myocarditis. An SH-dependent reduction of its expression and myocardial injury","volume":"91","author":"Suzuki","year":"1993","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ijcard.2007.04.062_bib14","first-page":"955","article-title":"Chronic effect of losartan in a murine model of dilated cardiomyopathy: comparison with captopril","volume":"273","author":"Kanda","year":"1995","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.ijcard.2007.04.062_bib15","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/00005344-199507000-00010","article-title":"Comparative effects of losartan, captopril, and enalapril on murine acute myocarditis due to encephalomyocarditis virus","volume":"26","author":"Araki","year":"1995","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.ijcard.2007.04.062_bib16","first-page":"H211","article-title":"Captopril suppresses interstitial fibrin deposition in coxsackievirus B3 myocarditis","volume":"272","author":"Takada","year":"1997","journal-title":"Am J Physiol"},{"key":"10.1016\/j.ijcard.2007.04.062_bib17","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1161\/01.CIR.81.3.1039","article-title":"Beneficial effects of captopril in acute coxsackievirus B3 murine myocarditis","volume":"81","author":"Rezkalla","year":"1990","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2007.04.062_bib18","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1016\/0002-8703(90)90251-R","article-title":"Effect of delayed captopril therapy on left ventricular mass and myonecrosis during acute coxsackievirus murine myocarditis","volume":"120","author":"Rezkalla","year":"1990","journal-title":"Am Heart J"},{"key":"10.1016\/j.ijcard.2007.04.062_bib19","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1161\/01.CIR.0000062690.79456.D0","article-title":"Captopril ameliorates myocarditis in acute experimental Chagas disease","volume":"107","author":"Leon","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2007.04.062_bib20","doi-asserted-by":"crossref","first-page":"3630","DOI":"10.4049\/jimmunol.139.11.3630","article-title":"Cardiac myosin induces myocarditis in genetically predisposed mice","volume":"139","author":"Neu","year":"1987","journal-title":"J Immunol"},{"key":"10.1016\/j.ijcard.2007.04.062_bib21","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.4049\/jimmunol.147.7.2141","article-title":"Myosin-induced acute myocarditis is a T cell-mediated disease","volume":"147","author":"Smith","year":"1991","journal-title":"J Immunol"},{"key":"10.1016\/j.ijcard.2007.04.062_bib22","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1006\/clin.1993.1103","article-title":"The role of T cells in myosin-induced autoimmune myocarditis","volume":"68","author":"Smith","year":"1993","journal-title":"Clin Immunol Immunopathol"},{"key":"10.1016\/j.ijcard.2007.04.062_bib23","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.4049\/jimmunol.157.4.1752","article-title":"Induction of autoimmunity in the absence of CD28 costimulation","volume":"157","author":"Bachmaier","year":"1996","journal-title":"J Immunol"},{"key":"10.1016\/j.ijcard.2007.04.062_bib24","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1006\/clin.1993.1104","article-title":"T cells in cardiac myosin-induced myocarditis","volume":"68","author":"Neu","year":"1993","journal-title":"Clin Immunol Immunopathol"},{"key":"10.1016\/j.ijcard.2007.04.062_bib25","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1084\/jem.178.5.1837","article-title":"The induction of experimental autoimmune myocarditis in mice lacking CD4 or CD8 molecules","volume":"178","author":"Penninger","year":"1993","journal-title":"J Exp Med"},{"key":"10.1016\/j.ijcard.2007.04.062_bib26","doi-asserted-by":"crossref","first-page":"5265","DOI":"10.4049\/jimmunol.163.10.5265","article-title":"Autoimmune myocarditis does not require B cells for antigen presentation","volume":"163","author":"Malkiel","year":"1999","journal-title":"J Immunol"},{"key":"10.1016\/j.ijcard.2007.04.062_bib27","doi-asserted-by":"crossref","first-page":"4094","DOI":"10.4049\/jimmunol.145.12.4094","article-title":"Cardiac myosin-induced myocarditis: heart autoantibodies are not involved in the induction of the disease","volume":"145","author":"Neu","year":"1990","journal-title":"J Immunol"},{"key":"10.1016\/j.ijcard.2007.04.062_bib28","doi-asserted-by":"crossref","first-page":"346","DOI":"10.4049\/jimmunol.171.1.346","article-title":"Captopril prevents experimental autoimmune myocarditis","volume":"171","author":"Godsel","year":"2003","journal-title":"J Immunol"},{"key":"10.1016\/j.ijcard.2007.04.062_bib29","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/S0024-3205(00)00654-8","article-title":"Reduction of cardiac endothelin-1 by angiotensin II type 1 receptor antagonist in viral myocarditis of mice","volume":"67","author":"Baba","year":"2000","journal-title":"Life Sci"},{"key":"10.1016\/j.ijcard.2007.04.062_bib30","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1161\/01.CIR.90.4.2051","article-title":"An angiotensin II receptor antagonist reduces myocardial damage in an animal model of myocarditis","volume":"90","author":"Tanaka","year":"1994","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2007.04.062_bib31","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/0024-3205(94)00730-6","article-title":"Effects of the angiotensin II receptor antagonist losartan on herpes simplex virus-type 2 infection of cultured vero and cardiac neonatal myocytes","volume":"55","author":"Gardner","year":"1994","journal-title":"Life Sci"},{"key":"10.1016\/j.ijcard.2007.04.062_bib32","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1023\/B:MCBI.0000021379.82282.53","article-title":"Beneficial effects of olmesartan, a novel angiotensin II receptor type 1 antagonist, upon acute autoimmune myocarditis","volume":"259","author":"Nimata","year":"2004","journal-title":"Mol Cell Biochem"},{"key":"10.1016\/j.ijcard.2007.04.062_bib33","first-page":"S105","article-title":"Angiotensin II type1 receptor blocker, valsartan, prevented cardiac fibrosis in rat cardiomyopathy after autoimmune myocarditis","volume":"41","author":"Tachikawa","year":"2003","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.ijcard.2007.04.062_bib34","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1093\/clinchem\/39.3.400","article-title":"Simplified enzymatic assay of angiotensin-converting enzyme in serum","volume":"39","author":"Groff","year":"1993","journal-title":"Clin Chem"},{"key":"10.1016\/j.ijcard.2007.04.062_bib35","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/0005-2795(75)90222-6","article-title":"Purification of cardiac myosin: application to hypertrophied myocardium","volume":"393","author":"Shiverick","year":"1975","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.ijcard.2007.04.062_bib36","doi-asserted-by":"crossref","first-page":"5643","DOI":"10.1128\/IAI.69.9.5643-5649.2001","article-title":"Cardiac myosin autoimmunity in acute Chagas heart disease","volume":"69","author":"Leon","year":"2001","journal-title":"Infect Immun"},{"key":"10.1016\/j.ijcard.2007.04.062_bib37","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1016\/0006-2952(71)90292-9","article-title":"Spectrophotometric assay and properties of the angiotensin-converting enzyme of rabbit lung","volume":"20","author":"Cushman","year":"1971","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.ijcard.2007.04.062_bib38","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1038\/ki.1984.111","article-title":"Captopril and immune regulation","volume":"25","author":"Delfraissy","year":"1984","journal-title":"Kidney Int"},{"key":"10.1016\/j.ijcard.2007.04.062_bib39","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1007\/BF02003227","article-title":"Differential effects of captopril and enalapril, two angiotensin converting enzyme inhibitors, on immune reactivity in experimental lupus disease","volume":"31","author":"Tarkowski","year":"1990","journal-title":"Agents Actions"},{"key":"10.1016\/j.ijcard.2007.04.062_bib40","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1097\/00004872-199105000-00001","article-title":"Cardioprotective potential of angiotensin converting enzyme inhibitors","volume":"9","author":"Gavras","year":"1991","journal-title":"J Hypertens"},{"key":"10.1016\/j.ijcard.2007.04.062_bib41","first-page":"25","article-title":"Contribution of kinins to the cardiovascular actions of angiotensin-converting enzyme inhibitors","volume":"47","author":"Linz","year":"1995","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.ijcard.2007.04.062_bib42","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S1071-9164(97)90047-6","article-title":"Antihypertensive and cardioprotective effects after angiotensin-converting enzyme inhibition: role of kinins","volume":"3","author":"Tschope","year":"1997","journal-title":"J Card Fail"},{"key":"10.1016\/j.ijcard.2007.04.062_bib43","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1515\/BC.2001.007","article-title":"Kinins, receptors, kininases and inhibitors-where did they lead us?","volume":"382","author":"Erdos","year":"2001","journal-title":"Biol Chem"},{"key":"10.1016\/j.ijcard.2007.04.062_bib44","doi-asserted-by":"crossref","first-page":"S346","DOI":"10.1097\/01.fjc.0000166265.09550.7c","article-title":"Endogenous bradykinin suppresses myocardial fibrosis through the cardiac-generated endothelin system under chronic angiotensin-converting enzyme inhibition in heart failure","volume":"44","author":"Fujii","year":"2004","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.ijcard.2007.04.062_bib45","first-page":"R514","article-title":"Enalapril and captopril enhance antioxidant defenses in mouse tissues","volume":"272","author":"de Cavanagh","year":"1997","journal-title":"Am J Physiol"}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527307009199?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527307009199?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,2,15]],"date-time":"2024-02-15T01:48:38Z","timestamp":1707961718000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527307009199"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,3]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,3]]}},"alternative-id":["S0167527307009199"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2007.04.062","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2008,3]]}}}